Document is current
Any future updates will be listed below
-
Authors
Moon, Andrew M. https://orcid.org/0000-0001-7163-2062
Swier, Rachel M.
Lane, Lindsay M.
Barritt, A. Sidney IV
Sanoff, Hanna K.
Olshan, Andrew F.
Wheeler, Stephanie B.
Ioannou, George N.
Kim, Nicole J.
Hagan, Scott
Vutien, Philip
Benefield, Thad
Henderson, Louise M.
-
Funding
Funding for this research was provided by:
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (Development Funding Program)
American Association for the Study of Liver Diseases (Clinical Translational and Outcomes Research Award)
- License Information
-
More Information
Article History
Received: 22 September 2023
Accepted: 9 April 2024
First Online: 23 April 2024
Declarations
:
: AMM: Consultant for TARGET RWE. RMS: No disclosures or conflicts of interest. LML: No disclosures or conflicts of interest. ASB: Consultant for TARGET RWE. HKS: Research funding (to institution) from AstraZeneca, F Hoffman La Roche, Amgen, Bristol-Myers Squibb, Pfizer, BioMed Valley Discoveries, Rgenix, Exelis. AFS: No disclosures or conflicts of interest. SBW: Receives unrelated grant funding paid to institution from Pfizer Foundation and Astra Zeneca. GNI: No disclosures or conflicts of interest. NJK: No disclosures or conflicts of interest. SH: No disclosures or conflicts of interest. PV: No disclosures or conflicts of interest. TB: No disclosures or conflicts of interest. LMH: No disclosures or conflicts of interest.
